Propolis is a sticky substance that bees make and which they use to seal the inside of their hives. Supplements manufacturers put the same propolis into capsules and tablets intended to stimulate the immune system. Researchers at New York University may now have discovered a new application for propolis. In the Journal of Cancer Science and Therapy they describe how propolis in theory can protect women against breast cancer.
Propolis is a sticky substance that bees make and which they use to seal the inside of their hives. Supplements manufacturers put the same propolis into capsules and tablets intended to stimulate the immune system. Researchers at New York University may now have discovered a new application for propolis. In the Journal of Cancer Science and Therapy they describe how propolis in theory can protect women against breast cancer.
Researchers have known for several years already that propolis kills cancer cells in test tubes. Scientists suspect that the cancer-inhibitory effect of propolis is due to flavonoid compounds such as chrysin and quercetin, decano-acid analogues and above all caffeic acid phenethyl ester, often abbreviated to CAPE.
Researchers at New York University recently published the results of in-vitro studies in which caffeic acid phenethyl ester was shown to kill hormone-sensitive and hormone-insensitive breast cancer cells [Cancer Lett. 2011 Sep 1;308(1):43-53.] and also breast cancer stem cells. [Invest New Drugs. 2012 Aug;30(4):1279-88.]
The reason that scientists are so interested in caffeic acid phenethyl ester is its high bioavailability. Researchers find the molecule in unexpectedly high concentrations in the blood after intake. The structural formula of caffeic acid phenethyl ester is shown here.
Propolis is a sticky substance that bees make and which they use to seal the inside of their hives. Supplements manufacturers put the same propolis into capsules and tablets intended to stimulate the immune system. Researchers at New York University may now have discovered a new application for propolis. In the Journal of Cancer Science and Therapy they describe how propolis in theory can protect women against breast cancer.
Propolis is a sticky substance that bees make and which they use to seal the inside of their hives. Supplements manufacturers put the same propolis into capsules and tablets intended to stimulate the immune system. Researchers at New York University may now have discovered a new application for propolis. In the Journal of Cancer Science and Therapy they describe how propolis in theory can protect women against breast cancer.
The chemical structure of caffeic acid phenethyl ester resembles that of vorinostat, a relatively new anti-cancer medicine. The chemical structure of vorinostat is the lower of the two on the right. Merck has marketed Vorinostat under the name Zolinza since 2006. Given the similarities between the two compounds, the researchers wondered whether the naturally occurring caffeic acid phenethyl ester would work in the same way as vorinostat, which attaches itself to the histone deacetylase enzyme.
The figure below shows how this happens. Once vorinostat [SAHA] has nestled in the enzyme, the histone deacetylase can no longer do its work. So vorinostat is a histone deacetylase inhibitor.
Histone deacetylases tidy up in the cell nucleus. They wrap up DNA so the strands of genetic material are not just floating around in the cell, so they don’t get in the way of other processes and don’t get damaged either. Because the cells can’t read wrapped up DNA, histone deacetylases therefore deactivate genes. Only temporarily, if things go as they are supposed to.
But cancer cells abuse histone deacetylases, and use them to permanently deactivate many genes. Cancer cells deactivate as many functions as they can so they can divert more energy to their own growth. Oncologists hope that histone deacetylase inhibitors can reactivate these functions, so that cancer cells become more vulnerable and can be more easily fought with chemotherapy or immunotherapy.
The figure below shows that both caffeic acid phenethyl ester and the natural propolis extract deactivate histone deacetylase in hormone-sensitive MCF-7 breast cancer cells. The thicker the clump, the lazier the histone deacetylase is. As you can see, propolis works better than the pure caffeic acid phenethyl ester.
The figure above shows that caffeic acid phenethyl ester kills above all propolis MCF=7 cells. The researchers also observed the same thing in cancer cells that had no receptors for estradiol or progesterone.
Although histone deacetylase inhibitors activate genes, propolis and caffeic acid phenethyl ester reduce the number of receptors for estradiol and progesterone in the MCF-7 cells. If propolis does the same in other cell types, then propolis might be an interesting for athletes who want to lower their oestrogen levels.
“These results of CAPE are present in the naturopathic formulation of propolis, a widely available natural substance with an extended safety record, making it a naturally-occurring and readily available epigenetic agent with great potential in breast cancer and oncology in general”, the researchers conclude.
Propolis and its Active Component, Caffeic Acid Phenethyl Ester (CAPE), Modulate Breast Cancer Therapeutic Targets via an Epigenetically Mediated Mechanism of Action.
Omene C1, Kalac M1, Wu J2, Marchi E3, Frenkel K4, O’Connor OA3.
Abstract
Alternative remedies for cancer treatment is a multi-billion dollar industry. In particular, breast cancer (BC) patients use alternative and natural remedies more frequently than patients with other malignancies. Propolis is an example of a honeybee-produced naturopathic formulation, contents of which differ by geographic location. It is readily available, affordable, and in use safely since ancient times globally. Caffeic acid phenethyl ester (CAPE) is a major active component in propolis and is thought to be responsible for its varied properties, including antibacterial, antiviral, antifungal, antioxidant, anti-inflammatory and anticancer. CAPE is effective in many models of human cancer, including BC as we have previously shown. CAPE affects genes associated with tumor cell growth and survival, angiogenesis and chemoresistance. We demonstrate that these are related in part to CAPE’s role as a histone deacetylase inhibitor, a class of drugs designated as epigenetic agents that modulate the activities of oncogenes and tumor suppressor genes. CAPE and propolis, cause an accumulation of acetylated histone proteins in MCF-7 (ER+) and MDA-MB-231 (ER-/PR-/Her2-) cells with associated decreases in ER and PR in MCF-7 cells, and upregulation of ER and decrease in EGFR in MDA-231 cells. In addition, these products reduced activated phosphorylated Her2 protein in SKBR3 (Her2 +) cells. Interestingly, propolis, when normalized for CAPE content, appears to be more potent than CAPE alone similarly to the greater effects of complete foods than isolated components. These data provide a potential mechanistic basis for one of the oldest naturopathic agents used in medicine and cancer treatment.
PMID: 24466386 [PubMed] PMCID: PMC3898618
Source: http://www.ncbi.nlm.nih.gov/pubmed/24466386
